Terms: = Breast cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Treatment
20 results:
1. The Military Health System: Minimizing Disparities in breast cancer treatment.
Liggett JR; Norris EA; Rush TM; Sicignano NM; Oxner C
Mil Med; 2023 Nov; 188(Suppl 6):494-502. PubMed ID: 37948201
[TBL] [Abstract] [Full Text] [Related]
2. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
4. Survival and prognostic factors in oligometastatic breast cancer.
van Ommen-Nijhof A; Steenbruggen TG; Capel L; Vergouwen M; Vrancken Peeters MT; Wiersma TG; Sonke GS
Breast; 2023 Feb; 67():14-20. PubMed ID: 36549169
[TBL] [Abstract] [Full Text] [Related]
5. Identifying Patients Whose Symptoms Are Underrecognized During treatment With breast Radiotherapy.
Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
[TBL] [Abstract] [Full Text] [Related]
6. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
[TBL] [Abstract] [Full Text] [Related]
7. Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer.
Greally M; Kielty J; Watson GA; Das G; Malouf C; McSorley L; Coleman N; Quinn C; McDermott EW; Gullo G; Crown J; Prichard RS; Kelly CM; Walshe JM
Ir J Med Sci; 2019 Feb; 188(1):59-67. PubMed ID: 29766409
[TBL] [Abstract] [Full Text] [Related]
8. Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant treatment of ERBB2/HER2-Positive breast cancer: Analysis of the NSABP B-31 Trial.
Gavin PG; Song N; Kim SR; Lipchik C; Johnson NL; Bandos H; Finnigan M; Rastogi P; Fehrenbacher L; Mamounas EP; Swain SM; Wickerham DL; Geyer CE; Jeong JH; Costantino JP; Wolmark N; Paik S; Pogue-Geile KL
JAMA Oncol; 2017 Mar; 3(3):335-341. PubMed ID: 27812689
[TBL] [Abstract] [Full Text] [Related]
9. [Advances of the Role of Ezrin in Migration and Invasion of breast cancer Cells].
Long ZY; Wang TH
Sheng Li Ke Xue Jin Zhan; 2016 Feb; 47(1):21-6. PubMed ID: 27424401
[TBL] [Abstract] [Full Text] [Related]
10. Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.
Hoppe R; Achinger-Kawecka J; Winter S; Fritz P; Lo WY; Schroth W; Brauch H
Eur J Cancer; 2013 Nov; 49(17):3598-608. PubMed ID: 23968733
[TBL] [Abstract] [Full Text] [Related]
11. Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.
Weigand S; Herting F; Maisel D; Nopora A; Voss E; Schaab C; Klammer M; Tebbe A
Cancer Res; 2012 Sep; 72(17):4329-39. PubMed ID: 22777824
[TBL] [Abstract] [Full Text] [Related]
12. Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.
Révillion F; Lhotellier V; Hornez L; Leroy A; Baranzelli MC; Giard S; Bonneterre J; Peyrat JP
Int J Biol Markers; 2008; 23(1):10-7. PubMed ID: 18409145
[TBL] [Abstract] [Full Text] [Related]
13. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy.
Huang O; Wang L; Shen K; Lin H; Hu Z; Liu G; Wu J; Lu J; Shao Z; Han Q; Shen Z
Breast Cancer Res Treat; 2008 Feb; 107(3):379-87. PubMed ID: 17457670
[TBL] [Abstract] [Full Text] [Related]
15. Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest.
Andersen K; Smith-Sørensen B; Pedersen KB; Hovig E; Myklebost O; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2003 Jun; 88(12):1995-2001. PubMed ID: 12799648
[TBL] [Abstract] [Full Text] [Related]
16. Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.
Molinari A; Calcabrini A; Meschini S; Stringaro A; Crateri P; Toccacieli L; Marra M; Colone M; Cianfriglia M; Arancia G
Curr Protein Pept Sci; 2002 Dec; 3(6):653-70. PubMed ID: 12470219
[TBL] [Abstract] [Full Text] [Related]
17. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
[TBL] [Abstract] [Full Text] [Related]
18. [Transcription factors of the PEA3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract] [Full Text] [Related]
19. Have changing treatment patterns affected outcome for operable breast cancer? Ten-year follow-up in 1288 patients, 1965 to 1978.
Cody HS; Laughlin EH; Trillo C; Urban JA
Ann Surg; 1991 Apr; 213(4):297-307. PubMed ID: 2009011
[TBL] [Abstract] [Full Text] [Related]
20. [Surgical treatment of breast cancer in elderly women--analysis of 244 patients].
Zhan YQ; Li GC
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):149-51. PubMed ID: 3208657
[TBL] [Abstract] [Full Text] [Related]
